ATA504374A - Verfahren zur herstellung neuer haptensteroide - Google Patents

Verfahren zur herstellung neuer haptensteroide

Info

Publication number
ATA504374A
ATA504374A AT504374A AT504374A ATA504374A AT A504374 A ATA504374 A AT A504374A AT 504374 A AT504374 A AT 504374A AT 504374 A AT504374 A AT 504374A AT A504374 A ATA504374 A AT A504374A
Authority
AT
Austria
Prior art keywords
haptensteroids
producing new
producing
new
new haptensteroids
Prior art date
Application number
AT504374A
Other languages
English (en)
Other versions
AT343295B (de
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of ATA504374A publication Critical patent/ATA504374A/de
Application granted granted Critical
Publication of AT343295B publication Critical patent/AT343295B/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/823—Immunogenic carrier or carrier per se
AT504374A 1973-06-18 1974-06-18 Verfahren zur herstellung neuer haptensteroide AT343295B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7322114A FR2235949B1 (de) 1973-06-18 1973-06-18

Publications (2)

Publication Number Publication Date
ATA504374A true ATA504374A (de) 1977-09-15
AT343295B AT343295B (de) 1978-05-26

Family

ID=9121104

Family Applications (1)

Application Number Title Priority Date Filing Date
AT504374A AT343295B (de) 1973-06-18 1974-06-18 Verfahren zur herstellung neuer haptensteroide

Country Status (16)

Country Link
US (1) US3922292A (de)
JP (4) JPS5827280B2 (de)
AT (1) AT343295B (de)
BE (1) BE816457A (de)
BR (1) BR7404979D0 (de)
CA (1) CA1032927A (de)
DE (1) DE2429040C2 (de)
DK (1) DK322274A (de)
ES (3) ES427318A1 (de)
FR (1) FR2235949B1 (de)
GB (2) GB1478356A (de)
IE (1) IE41524B1 (de)
LU (1) LU70329A1 (de)
NL (1) NL7408041A (de)
SE (1) SE402461B (de)
ZA (1) ZA743841B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2277821A1 (fr) * 1974-07-10 1976-02-06 Roussel Uclaf Nouveaux haptenes derives de la progesterone, leur procede de preparation et leur application a la fabrication d'antigenes
FR2377417A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides substitues en 11b, ainsi que leur procede de preparation
FR2377419A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 11b-substitues 1,3,5 (10) trieniques, leur procede de preparation et leur application comme medicament
FR2377418A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments
NL7701384A (nl) * 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
DE3572177D1 (de) 1984-10-19 1989-09-14 Nihon Mediphysics Co Ltd Imunoassay for estriol-3-sulfate
FR2643638B1 (fr) * 1989-02-24 1991-06-14 Roussel Uclaf Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
FR2665901B2 (fr) * 1989-02-24 1994-07-29 Roussel Uclaf Nouveaux 19-nor sterouides ayant en position 11beta une chaine carbonee comportant une fonction amide, leur preparation, leur application comme medicaments.
DE69128820T2 (de) * 1990-08-14 1998-06-10 Hoechst Marion Roussel Inc Neue 19-Nor Steroide, die eine Amid tragende Gruppe in der 11-Beta-Stelle haben, ihre Herstellung, ihre Verwendung als Medikamente und pharmazeutische Präparate davon
JPH059418U (ja) * 1991-07-12 1993-02-09 広島アルミニウム工業株式会社 電磁コンロ用発熱器
JPH07297707A (ja) * 1994-04-27 1995-11-10 Nec Corp 位相同期発振回路
ATE363908T1 (de) 1996-04-09 2007-06-15 Univ Edinburgh Verwendung von 7-alpha-substituierten steroiden zur behandlung von neuropsychiatrischen erkrankungen
EP1771462B1 (de) * 2004-07-27 2010-09-29 Sicor Inc. Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
US7910755B2 (en) * 2004-09-29 2011-03-22 Harbor Biosciences, Inc. Stem cell expansion and uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3211756A (en) * 1963-07-23 1965-10-12 Searle & Co 3-hydroxyimino-17alpha-(lower alkyl)-5alpha-androstan-17beta-ols and the optionally substituted 3-acyloxyimino and 3-alkoxyimino derivatives corresponding
DE1668682A1 (de) * 1967-03-14 1971-09-23 Searle & Co Gegebenenfalls in 17-Stellung alkylierte 11,13ss-Dialkylgona-1,3,5(10)-trien-3,17ss-diole und deren Ester

Also Published As

Publication number Publication date
IE41524B1 (en) 1980-01-30
IE41524L (en) 1974-12-18
JPS601200A (ja) 1985-01-07
FR2235949A1 (de) 1975-01-31
ES427318A1 (es) 1976-09-16
ES448013A1 (es) 1977-07-01
JPS5934200B2 (ja) 1984-08-21
AU7014874A (en) 1975-12-18
LU70329A1 (de) 1975-03-06
US3922292A (en) 1975-11-25
JPS5036451A (de) 1975-04-05
NL7408041A (de) 1974-12-20
GB1478357A (en) 1977-06-29
DE2429040C2 (de) 1985-10-31
ZA743841B (en) 1976-01-28
DE2429040A1 (de) 1975-01-09
BR7404979D0 (pt) 1975-01-21
JPS5827280B2 (ja) 1983-06-08
ES448012A1 (es) 1977-07-01
CA1032927A (en) 1978-06-13
JPS5890597A (ja) 1983-05-30
SE7407108L (de) 1974-12-19
SE402461B (sv) 1978-07-03
JPS5838440B2 (ja) 1983-08-23
DK322274A (de) 1975-02-10
BE816457A (fr) 1974-12-17
JPS5890600A (ja) 1983-05-30
AT343295B (de) 1978-05-26
FR2235949B1 (de) 1978-03-17
GB1478356A (en) 1977-06-29
JPS6241719B2 (de) 1987-09-04

Similar Documents

Publication Publication Date Title
AT338261B (de) Verfahren zur herstellung neuer pyridinverbindungen
AT336631B (de) Verfahren zur herstellung neuer diphenylharnstoffe
DD110652A5 (de) Verfahren zur herstellung neuer 1-aryloxy-2-hydroxy-3-alkinylaminopropane
ATA504374A (de) Verfahren zur herstellung neuer haptensteroide
ATA588973A (de) Verfahren zur herstellung neuer phenoxypropanolamine
AT337166B (de) Verfahren zur herstellung neuer substituierter benzocycloalkenylalkane
ATA208576A (de) Verfahren zur herstellung neuer alfa-athylbenzhydrol-derivate
AT341118B (de) Verfahren zur herstellung neuer dotriacontapeptidamide
AT337165B (de) Verfahren zur herstellung neuer phenylpropenylaminderivate
AT352911B (de) Verfahren zur herstellung neuer ergopeptin- derivate
AT334365B (de) Verfahren zur herstellung neuer thiazol-5-methanol-derivate
AT338245B (de) Verfahren zur herstellung neuer aryloxyalkyldiketonen
AT327881B (de) Verfahren zur herstellung neuer furanderivate
AT326653B (de) Verfahren zur herstellung neuer 2-amino-4-h-pyrane
AT333950B (de) Verfahren zur herstellung neuer cepham-verbindungen
AT331224B (de) Verfahren zur herstellung neuer alfa-carboxy-benzylsulfonsaureester
AT336200B (de) Verfahren zur herstellung neuer cardenolidacetale
ATA986376A (de) Verfahren zur herstellung neuer haptensteroide
AT340404B (de) Verfahren zur herstellung neuer benzoylbenzocycloalkene
AT322542B (de) Verfahren zur herstellung neuer nitrofuranverbindungen
ATA630474A (de) Verfahren zur herstellung neuer pyridazinderivate
AT345484B (de) Verfahren zur herstellung neuer dotriacontapeptidamide
ATA158875A (de) Verfahren zur herstellung neuer pseudotrisaccharide
ATA435577A (de) Verfahren zur herstellung neuer phenylbutenone
AT323327B (de) Verfahren zur herstellung neuer polyaminverbindungen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee